Kenvue Announces Launch of Secondary Offering
Kenvue Inc. (KVUE)
Company Research
Source: Business Wire
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) (“Kenvue”) announced today the launch of a secondary underwritten public offering (the “Offering”) of 182,329,550 shares of its common stock (the “Shares”). Kenvue is not selling any shares of common stock and will not receive any proceeds from the sale of the Shares in the Offering or from the debt-for-equity exchange (as described below).In connection with the Offering, Johnson & Johnson (NYSE: JNJ) is expected to exchange 182,329,550 shares of Kenvue’s common stock for indebtedness of Johnson & Johnson expected to be held by Goldman Sachs & Co. LLC and J.P. Morgan (collectively, the “Selling Shareholders”). Following the debt-for-equity exchange, if consummated, the Selling Shareholders intend to sell the Shares to the underwriters in the Offering. After the completion of the proposed Offering, Johnson & Johnson will no longer own any shares of Kenvue’s common stock.Goldman Sachs & Co. LLC, J.P. Morgan and BofA Securitie
Show less
Read more
Impact Snapshot
Event Time:
KVUE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KVUE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KVUE alerts
High impacting Kenvue Inc. news events
Weekly update
A roundup of the hottest topics
KVUE
News
- J&J Acquires Experimental Eczema Drug in $1.25 Billion Cash Deal [BNN Bloomberg (Canada)]BNN Bloomberg
- Kenvue Inc. (NYSE: KVUE) had its "neutral" rating re-affirmed by analysts at Citigroup Inc.. They now have a $21.00 price target on the stock.MarketBeat
- Kenvue Announces Participation in Deutsche Bank's dbAccess Global Consumer ConferenceBusiness Wire
- Kenvue Announces Pricing of Secondary OfferingBusiness Wire
- Kenvue Inc. (NYSE:KVUE) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
KVUE
Earnings
- 5/7/24 - Beat
KVUE
Sec Filings
- 5/28/24 - Form 4
- 5/28/24 - Form 4
- 5/28/24 - Form 4
- KVUE's page on the SEC website